- Home
- OPT vs OSBC Comparison
OPT vs OSBC Comparison
Compare OPT & OSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPT
- OSBC
- Stock Information
- Founded
- OPT 1984
- OSBC 1981
- Country
- OPT Australia
- OSBC United States
- Employees
- OPT N/A
- OSBC N/A
- Industry
- OPT Biotechnology: Biological Products (No Diagnostic Substances)
- OSBC Major Banks
- Sector
- OPT Health Care
- OSBC Finance
- Exchange
- OPT Nasdaq
- OSBC Nasdaq
- Market Cap
- OPT 767.9M
- OSBC 838.3M
- IPO Year
- OPT 2020
- OSBC N/A
- Fundamental
- Price
- OPT $3.22
- OSBC $17.31
- Analyst Decision
- OPT Strong Buy
- OSBC Buy
- Analyst Count
- OPT 1
- OSBC 4
- Target Price
- OPT $12.00
- OSBC $18.75
- AVG Volume (30 Days)
- OPT 13.0K
- OSBC 203.5K
- Earning Date
- OPT 08-30-2024
- OSBC 01-22-2025
- Dividend Yield
- OPT N/A
- OSBC 1.31%
- EPS Growth
- OPT N/A
- OSBC N/A
- EPS
- OPT N/A
- OSBC 1.85
- Revenue
- OPT $261,859.00
- OSBC $264,069,000.00
- Revenue This Year
- OPT N/A
- OSBC N/A
- Revenue Next Year
- OPT $46,864.64
- OSBC N/A
- P/E Ratio
- OPT N/A
- OSBC $9.80
- Revenue Growth
- OPT N/A
- OSBC N/A
- 52 Week Low
- OPT $1.79
- OSBC $13.00
- 52 Week High
- OPT $5.45
- OSBC $19.37
- Technical
- Relative Strength Index (RSI)
- OPT 40.67
- OSBC 35.81
- Support Level
- OPT $3.15
- OSBC $18.21
- Resistance Level
- OPT $3.78
- OSBC $18.63
- Average True Range (ATR)
- OPT 0.18
- OSBC 0.44
- MACD
- OPT -0.00
- OSBC -0.19
- Stochastic Oscillator
- OPT 25.91
- OSBC 3.85
About OPT Opthea Limited
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.
About OSBC Old Second Bancorp Inc.
Old Second Bancorp Inc is a bank holding company. It provides consumer and commercial banking products such as demand, money market, savings, time deposit, and individual retirement as well as commercial, industrial, consumer, and real estate lending, including installment loans, student loans, agricultural loans, lines of credit and overdraft checking, safe deposit operations, trust services, wealth management services, and additional services tailored to the needs of individual customers, corporates, small-medium enterprises. The company's revenue consists of interest, commission, payments, and other income.